The role of circRNA in breast cancer drug resistance
- PMID: 39713143
- PMCID: PMC11662897
- DOI: 10.7717/peerj.18733
The role of circRNA in breast cancer drug resistance
Abstract
Among women with cancer, breast cancer has surpassed lung cancer to become the most prevalent type of cancer globally. High-throughput sequencing of breast cancer tissues from many patients has revealed significant variations in circRNA expression across different types of breast cancer. Chemotherapy is currently a very important method for treating breast cancer; however, as the number of chemotherapy sessions increases and considering factors such as the patient's immune response, drug resistance has become a challenging issue in treating breast cancer. It is well known that drug resistance is associated with multiple factors, and different resistance mechanisms involve different roles of circRNA. This review consolidates literature from the past 5 years and addresses the shortcomings in the broad description of circRNA's role in breast cancer drug resistance. It categorizes and describes the drug resistance and its mechanisms in different types of breast cancer, as well as the roles of circRNA and signaling pathways in drug resistance.
Keywords: Antineoplastic; BC; Drug resistance; circRNA.
© 2024 Yang and Li.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.Gene. 2024 Jul 20;916:148424. doi: 10.1016/j.gene.2024.148424. Epub 2024 Apr 7. Gene. 2024. PMID: 38588933 Review.
-
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells.Cell Death Dis. 2023 Jul 31;14(7):482. doi: 10.1038/s41419-023-06006-5. Cell Death Dis. 2023. PMID: 37524698 Free PMC article.
-
Circular RNA; a new biomarker for breast cancer: A systematic review.J Cell Physiol. 2020 Jul;235(7-8):5501-5510. doi: 10.1002/jcp.29558. Epub 2020 Jan 27. J Cell Physiol. 2020. PMID: 31985056
-
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.Mol Ther. 2019 Sep 4;27(9):1638-1652. doi: 10.1016/j.ymthe.2019.05.011. Epub 2019 May 17. Mol Ther. 2019. PMID: 31153828 Free PMC article.
-
Integrated Analysis of Circular RNA-Associated ceRNA Network Reveals Potential circRNA Biomarkers in Human Breast Cancer.Comput Math Methods Med. 2021 Dec 20;2021:1732176. doi: 10.1155/2021/1732176. eCollection 2021. Comput Math Methods Med. 2021. Retraction in: Comput Math Methods Med. 2023 Nov 1;2023:9780596. doi: 10.1155/2023/9780596. PMID: 34966440 Free PMC article. Retracted.
References
-
- Alhasan AA, Izuogu OG, Al-Balool HH, Steyn JS, Evans A, Colzani M, Ghevaert C, Mountford JC, Marenah L, Elliott DJ, Santibanez-Koref M, Jackson MS. Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood. 2016;127(9):e1–e11. doi: 10.1182/blood-2015-06-649434. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous